Feasibility of large-scale population testing for SARS-CoV-2 detection by self-testing at home
Abstract The simplicity and low cost of rapid point-of-care tests greatly facilitate large-scale population testing, which can contribute to controlling the spread of the COVID-19 virus. We evaluated the applicability of a self-testing strategy for SARS-CoV2 in a population-based, cross-sectional st...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7b9e4027475d423480ce024e071262c0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:7b9e4027475d423480ce024e071262c0 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:7b9e4027475d423480ce024e071262c02021-12-02T14:35:33ZFeasibility of large-scale population testing for SARS-CoV-2 detection by self-testing at home10.1038/s41598-021-89236-x2045-2322https://doaj.org/article/7b9e4027475d423480ce024e071262c02021-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-89236-xhttps://doaj.org/toc/2045-2322Abstract The simplicity and low cost of rapid point-of-care tests greatly facilitate large-scale population testing, which can contribute to controlling the spread of the COVID-19 virus. We evaluated the applicability of a self-testing strategy for SARS-CoV2 in a population-based, cross-sectional study in Cantabria, Spain, between April and May 2020. For the self-testing strategy, participants received the necessary material for the self-collection of blood and performance of a rapid antibody test using lateral flow immunoassay at home without the supervision of healthcare personnel. A total of 1,022 participants were enrolled. Most participants correctly performed the COVID-19 self-test the first time (91.3% [95% CI 89.4–92.9]). Only a minority of the participants (0.7%) needed the help of healthcare personnel, while 6.9% required a second kit delivery, for a total valid test result in 96.9% of the participants. Incorrect use of the self-test was not associated with the educational level, age over 65, or housing area. Prevalence of IgG antibodies against SARS-CoV2 for subjects with a valid rapid test result was 3.1% (95% CI 2.2–4.4), similar to the seroprevalence result obtained using a conventional approach carried out by healthcare professionals. In conclusion, COVID-19 self-testing should be considered as a screening tool.Paula IruzubietaTatiana Fernández-LanasLaura RasinesLorena CayonAna Álvarez-CanceloAlvaro Santos-LasoAgustín García-BlancoSoraya Curiel-OlmoJoaquín CabezasReinhard WallmannEmilio FábregaVíctor M. Martínez-TaboadaJosé L. HernándezMarcos López-HoyosJeffrey V. LazarusJavier CrespoNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-10 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Paula Iruzubieta Tatiana Fernández-Lanas Laura Rasines Lorena Cayon Ana Álvarez-Cancelo Alvaro Santos-Laso Agustín García-Blanco Soraya Curiel-Olmo Joaquín Cabezas Reinhard Wallmann Emilio Fábrega Víctor M. Martínez-Taboada José L. Hernández Marcos López-Hoyos Jeffrey V. Lazarus Javier Crespo Feasibility of large-scale population testing for SARS-CoV-2 detection by self-testing at home |
description |
Abstract The simplicity and low cost of rapid point-of-care tests greatly facilitate large-scale population testing, which can contribute to controlling the spread of the COVID-19 virus. We evaluated the applicability of a self-testing strategy for SARS-CoV2 in a population-based, cross-sectional study in Cantabria, Spain, between April and May 2020. For the self-testing strategy, participants received the necessary material for the self-collection of blood and performance of a rapid antibody test using lateral flow immunoassay at home without the supervision of healthcare personnel. A total of 1,022 participants were enrolled. Most participants correctly performed the COVID-19 self-test the first time (91.3% [95% CI 89.4–92.9]). Only a minority of the participants (0.7%) needed the help of healthcare personnel, while 6.9% required a second kit delivery, for a total valid test result in 96.9% of the participants. Incorrect use of the self-test was not associated with the educational level, age over 65, or housing area. Prevalence of IgG antibodies against SARS-CoV2 for subjects with a valid rapid test result was 3.1% (95% CI 2.2–4.4), similar to the seroprevalence result obtained using a conventional approach carried out by healthcare professionals. In conclusion, COVID-19 self-testing should be considered as a screening tool. |
format |
article |
author |
Paula Iruzubieta Tatiana Fernández-Lanas Laura Rasines Lorena Cayon Ana Álvarez-Cancelo Alvaro Santos-Laso Agustín García-Blanco Soraya Curiel-Olmo Joaquín Cabezas Reinhard Wallmann Emilio Fábrega Víctor M. Martínez-Taboada José L. Hernández Marcos López-Hoyos Jeffrey V. Lazarus Javier Crespo |
author_facet |
Paula Iruzubieta Tatiana Fernández-Lanas Laura Rasines Lorena Cayon Ana Álvarez-Cancelo Alvaro Santos-Laso Agustín García-Blanco Soraya Curiel-Olmo Joaquín Cabezas Reinhard Wallmann Emilio Fábrega Víctor M. Martínez-Taboada José L. Hernández Marcos López-Hoyos Jeffrey V. Lazarus Javier Crespo |
author_sort |
Paula Iruzubieta |
title |
Feasibility of large-scale population testing for SARS-CoV-2 detection by self-testing at home |
title_short |
Feasibility of large-scale population testing for SARS-CoV-2 detection by self-testing at home |
title_full |
Feasibility of large-scale population testing for SARS-CoV-2 detection by self-testing at home |
title_fullStr |
Feasibility of large-scale population testing for SARS-CoV-2 detection by self-testing at home |
title_full_unstemmed |
Feasibility of large-scale population testing for SARS-CoV-2 detection by self-testing at home |
title_sort |
feasibility of large-scale population testing for sars-cov-2 detection by self-testing at home |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/7b9e4027475d423480ce024e071262c0 |
work_keys_str_mv |
AT paulairuzubieta feasibilityoflargescalepopulationtestingforsarscov2detectionbyselftestingathome AT tatianafernandezlanas feasibilityoflargescalepopulationtestingforsarscov2detectionbyselftestingathome AT laurarasines feasibilityoflargescalepopulationtestingforsarscov2detectionbyselftestingathome AT lorenacayon feasibilityoflargescalepopulationtestingforsarscov2detectionbyselftestingathome AT anaalvarezcancelo feasibilityoflargescalepopulationtestingforsarscov2detectionbyselftestingathome AT alvarosantoslaso feasibilityoflargescalepopulationtestingforsarscov2detectionbyselftestingathome AT agustingarciablanco feasibilityoflargescalepopulationtestingforsarscov2detectionbyselftestingathome AT sorayacurielolmo feasibilityoflargescalepopulationtestingforsarscov2detectionbyselftestingathome AT joaquincabezas feasibilityoflargescalepopulationtestingforsarscov2detectionbyselftestingathome AT reinhardwallmann feasibilityoflargescalepopulationtestingforsarscov2detectionbyselftestingathome AT emiliofabrega feasibilityoflargescalepopulationtestingforsarscov2detectionbyselftestingathome AT victormmartineztaboada feasibilityoflargescalepopulationtestingforsarscov2detectionbyselftestingathome AT joselhernandez feasibilityoflargescalepopulationtestingforsarscov2detectionbyselftestingathome AT marcoslopezhoyos feasibilityoflargescalepopulationtestingforsarscov2detectionbyselftestingathome AT jeffreyvlazarus feasibilityoflargescalepopulationtestingforsarscov2detectionbyselftestingathome AT javiercrespo feasibilityoflargescalepopulationtestingforsarscov2detectionbyselftestingathome |
_version_ |
1718391138784641024 |